SCHEMBL30879233

SCHEMBL30879233

CC(C)[Si](C#Cc1c(-c2ccccc2Cl)c(=O)n(C)c2nc(Nc3ccc(N(C)CCN(C)C)cc3)ncc12)(C(C)C)C(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
WEE1 P30291 7/20 0.52
FGFR1 P11362 8/20 0.45
RIPK2 O43353 1/20 0.43
ACVR1 Q04771 1/20 0.43
NOD2 Q9HC29 1/20 0.43
KCNH2 Q12809 1/20 0.42
CCNT1 O60563 2/20 0.42
CDK9 P50750 2/20 0.42
CDK4 P11802 1/20 0.41
CCND1 P24385 1/20 0.41
SRC P12931 7/20 0.41
EGFR P00533 3/20 0.41
FGFR2 P21802 1/20 0.41
FGFR4 P22455 1/20 0.41
FGFR3 P22607 1/20 0.41
ABL1 P00519 5/20 0.40
PDGFRB P09619 5/20 0.40
PDGFRA P16234 5/20 0.40
MAPK14 Q16539 5/20 0.40
TNK2 Q07912 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30879066 0.93 FGFR1 (0.48) WEE1FGFR1RIPK2ACVR1NOD2
SCHEMBL30879118 0.92 WEE1 (0.42) WEE1FGFR1RIPK2ACVR1NOD2
SCHEMBL30879282 0.90 FGFR1 (0.42) WEE1FGFR1ACVR1KCNH2CCNT1
SCHEMBL30878874 0.90 FGFR1 (0.43) WEE1FGFR1RIPK2ACVR1NOD2
SCHEMBL30878690 0.90 FGFR4 (0.43) WEE1FGFR1CCNT1CDK9CDK4
SCHEMBL30878665 0.89 WEE1 (0.49) WEE1FGFR1RIPK2ACVR1NOD2
SCHEMBL30878325 0.89 WEE1 (0.58) WEE1FGFR1RIPK2ACVR1NOD2
SCHEMBL30879194 0.89 WEE1 (0.62) WEE1FGFR1RIPK2ACVR1NOD2
SCHEMBL30879105 0.89 FGFR1 (0.46) WEE1FGFR1RIPK2ACVR1NOD2
SCHEMBL30879162 0.88 EGFR (0.48) WEE1FGFR1KCNH2CDK4EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612148-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 EP disclosed
WO-2024094963-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-05-10 WO disclosed